NCT01766791

Brief Summary

A plethora of trials reported the positive effect of resistance exercise on functional and morphological parameters. Although a large amount of the studies used suboptimum devices and obsolete methods the results of these older studies were still considered as golden standard. The aim of the present study is thus to determine the proper effect of different resistance exercise protocols with and without adjuvant protein supplementation on functional and morphological muscle and body composition parameters in male untrained subjects 30-50 years old under special regard of modern medical imaging and segmentation technologies. Our general study hypothesis is that HIT-resistance exercise significantly impact relevant muscular parameters of the upper leg.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2013

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

January 7, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 11, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

March 21, 2014

Status Verified

March 1, 2014

Enrollment Period

1.2 years

First QC Date

January 7, 2013

Last Update Submit

March 20, 2014

Conditions

Keywords

resistance exercisemuscle massabdominal fatstrengthCoronary Heart Disease (CHD)-riskmyocardial mass

Outcome Measures

Primary Outcomes (1)

  • fat free Cross Sectional Area (CSA) upper leg

    fat free muscle cross sectional area of the upper leg at mid-femur via Quantitative Computed Tomography (QCT)

    change from baseline in fat free Cross Sectional Area at 5 months

Secondary Outcomes (1)

  • CSA upper leg

    change from baseline in CSA upper leg at 5 months

Other Outcomes (4)

  • intra-abdominal fat mass

    change from baseline in intra-abdominal fat mass at 5 months

  • maximum strength leg press

    change from baseline in maximum strength leg press at 5 months

  • metabolic syndrome score

    change from baseline in metabolic syndrome score at 5 months

  • +1 more other outcomes

Study Arms (4)

HIT-exercise, low repetition range

EXPERIMENTAL

High Intensity Resistance Exercise Training, low repetition range, \> 75% 1 Repetition Maximum (1RM)

Other: HIT-exercise, low repetition range

HIT-exercise, high repetition range

EXPERIMENTAL

High Intensity Resistance Exercise Training, high repetition range, 60 - \<75% 1RM

Other: HIT-exercise, high repetition range

HIT-exercise with protein

EXPERIMENTAL

High Intensity Resistance Exercise Training with protein supplementation

Other: HIT-exercise with protein

Control

PLACEBO COMPARATOR

No physical exercise intervention

Other: Control

Interventions

High Intensity Resistance Exercise Training, low repetition range, \> 75% 1RM

HIT-exercise, low repetition range

High Intensity Resistance Exercise Training, high repetition range, 60 - \< 75 1RM

HIT-exercise, high repetition range

High Intensity Resistance Exercise Training, low repetition range, \> 75% 1RM and Protein Supplementation

HIT-exercise with protein
ControlOTHER

control group, no intervention, maintenance of physical activity

Control

Eligibility Criteria

Age30 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • males
  • untrained (\< 2 h exercise/week, \< 1 h resistance exercise/week)
  • years old

You may not qualify if:

  • medication/diseases affecting intervention or study endpoints
  • history of intense resistance exercise (\> 3 h/week during the last decade)
  • very low physical capacity (\< 100 Watt at ergometry)
  • more than 2 weeks of absence during the interventional period
  • contraindication related to MRI-assessment (i.e. magnetizable intracorporal artefacts)
  • pathological changes of the heart
  • inflammable diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Medical Physics, University of Erlangen-Nurnberg

Erlangen, 91052, Germany

Location

Related Publications (2)

  • Tuttor M, von Stengel S, Kohl M, Lell M, Scharf M, Uder M, Wittke A, Kemmler W. High Intensity Resistance Exercise Training vs. High Intensity (Endurance) Interval Training to Fight Cardiometabolic Risk Factors in Overweight Men 30-50 Years Old. Front Sports Act Living. 2020 Jun 16;2:68. doi: 10.3389/fspor.2020.00068. eCollection 2020.

  • Scharf M, Oezdemir D, Schmid A, Kemmler W, von Stengel S, May MS, Uder M, Lell MM. Myocardial adaption to HI(R)T in previously untrained men with a randomized, longitudinal cardiac MR imaging study (Physical adaptions in Untrained on Strength and Heart trial, PUSH-trial). PLoS One. 2017 Dec 7;12(12):e0189204. doi: 10.1371/journal.pone.0189204. eCollection 2017.

MeSH Terms

Conditions

SarcopeniaObesityCoronary Disease

Interventions

Proteins

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Amino Acids, Peptides, and Proteins

Study Officials

  • Wolfgang Kemmler, PhD

    University of Erlangen-Nürnberg Medical School

    STUDY DIRECTOR
  • Andreas Wittke, MA

    University of Erlangen-Nürnberg Medical School

    PRINCIPAL INVESTIGATOR
  • Klaus Engelke, PhD

    University of Erlangen-Nürnberg Medical School

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2013

First Posted

January 11, 2013

Study Start

January 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

March 21, 2014

Record last verified: 2014-03

Locations